1. Introduction {#sec1}
===============

Worldwide cancer remains a significant problem with 12.7 million new cases being diagnosed in 2008. Globally cancer remains one of the leading causes of death and is responsible for 7.6 million deaths per year [@bib1], [@bib2]. In the UK each year, there are approximately 331,000 new cases of cancer and over 50,000 deaths each year in the 35--64 age groups. Surgery is the primary modality of cure and therefore post-operative management is important in cancer care [@bib3].

Although, outcomes are predominantly determined by cancer stage in patients with operable disease, post-operative complications are important in the disease progression [@bib4], [@bib5]. In particular, it has been shown that anastomotic leaks have a negative impact on both the short and long-term survival of patients with GI cancer [@bib6], [@bib7]. The basis of this relationship is not clear, however it has been proposed that the magnitude of the post-op systemic inflammatory response \[SIRS\] is an important determining factor [@bib4]. The magnitude of this SIRS response can be routinely quantified by serial C-reactive protein \[CRP\] concentration measurement in the post-operative period [@bib8].

Two recent meta-analyses including over 2000 patients have reported the importance of postoperative serum CRP measurement in the early diagnosis of postoperative infective complications and anastomotic leaks in patients undergoing colorectal surgery [@bib9], [@bib10]. Indeed, CRP thresholds have been reported as consistently predicting the development of post-operative infective complications and may be a guide to early discharge [@bib10], [@bib11], [@bib12].

However, this raises the question as to how this information might be used in clinical practice. For example, McDermott and coworkers \[2015\] have proposed that a CRP \<150 mg/L on days 3, 4 and 5, be used to indicate the likelihood of safe discharge postoperatively [@bib11]. In a recent study in the Netherlands the use of serial CRP monitoring has been proposed as a trigger for determining whether or not a post-operative CT should be carried out to investigate the presence of a possible post-operative complication [@bib13]. Also, it has been proposed that serial CRP monitoring may be used to determine the efficacy of ERAS protocols in the post-operative period [@bib8].

It is against this background that the present questionnaire based study was carried out. The aim was to assess the attitudes of surgeons to the use of serial post-operative CRP monitoring and its importance in their clinical decision making. In addition, to investigate the level of awareness of the postoperative CRP thresholds associated with the development of potential complications and to guide clinical decision making in the postoperative period including the decision to instigate a surgical, endoscopic or radiological intervention or in discharge planning. Finally, to assess the attitudes of surgeons to the incorporation of serial CRP monitoring into routine postoperative care protocols and guidelines.

2. Methods {#sec2}
==========

A web based survey that included 10 questions on the "Attitudes of surgeons to the use of postoperative markers of the systemic inflammatory response following elective surgery" was as follows.

2.1. Survey questions {#sec2.1}
---------------------

1.What is your surgical specialisation? Colorectal/Oesphagogastric/Hepatobiliary/Urology/Thoracic/Other \[please specify\]2.In what country are you based? *Open Text*3.What is your grade at present? *Consultant/Trainee/Other*4.Which of the following best describes the surgical unit in which you currently practice? *University Academic Unit/Teaching Hospital/Non-teaching Hospital/Other \[please state\]*5.Does your unit currently use an "enhanced recovery" or "fast track" programme following elective surgery? *yes/no*6.Do you currently perform any elective procedures using laparoscopic, robotic or other minimally invasive techniques? *yes/no*7.Is C-reactive protein measured routinely in your patients during the postoperative period following elective colorectal surgery? *yes/no*8.If you answered "Yes" to Q7: Do you currently use C-reactive protein \[CRP\] to guide decision making in the postoperative period \[e.g. to trigger investigation of potential complications or direct discharge\]? If you answer "Yes", please leave specific comments to elaborate. *yes/no*9.Are you aware of any existing literature examining the relationship between the magnitude of the postoperative systemic inflammatory response, in particular as measured by C-reactive protein \[CRP\], and outcomes following surgery? If so, please comment. *yes/no*10.Do you think that a measure of the postoperative systemic inflammatory response, such as C-reactive protein \[CRP\], should be included in postoperative care protocols or guidelines to guide postoperative decision making and/or discharge planning? *yes/no*

The survey was generated through the SurveyMonkey website \[[www.surveymonkey.com/](http://www.surveymonkey.com/){#intref0010}, SurveyMonkey, Palo Alto, USA\] and the access link emailed to the target cohort. The initial target cohort included surgeons who were part of the Association of Coloproctology of Great Britain and Ireland (ACPGBI) mailing list (n = 1092) however responses from this were few and so a further target cohort was selected from two recent meta-analysis [@bib1], [@bib2] and by performing a literature search for articles using the keywords cancer, inflammation, CRP, postoperative care, minimal access surgery, post-operative complications and discharge planning up to the end of 2015 (n = 270). Once a comprehensive list of articles was obtained, the email addresses of the corresponding authors from each article formed the basis of the mailing list for distribution. These emails were then reviewed to ascertain the specialty of the authors to ensure that they were surgeons.

Once this was completed an email was sent out to the identified surgeons clearly stating that the role of the study was to assess the application of the systemic inflammatory response using CRP in the postoperative care of patients following surgical excisions of resectable cancers and that participation was on a voluntary basis. Software on the website ensured duplication of response from the same individual was not recorded. No incentives were used to promote or encourage participation.

The initial survey to cohort 1 was distributed in November 2015 and remained open for six weeks in total. Following a literature review the survey was sent out again to cohort 2 on 3rd June 2016 with a reminder sent out 21 days later. The survey remained open for 3 weeks and was closed on 15th July. Data were analysed and graphs of results were compiled using Microsoft Excel 2007 \[Redmond, WA, USA\].

3. Results {#sec3}
==========

In total, 69 people completed the survey. There were 29 from cohort 1 (2.7%) and 40 from cohort 2 (14.8%) giving an overall response rate of 5.9%.

The response to survey question 1 is shown in [Fig. 1](#fig1){ref-type="fig"} and 64% of respondents were colorectal surgeons, 12% were oesophagogastric surgeons and 14%\] were hepatobiliary surgeons. The response to question 2 is shown in [Fig. 2](#fig2){ref-type="fig"} and 76% of respondents were from Europe, 13% from Asia and 7% from the Americas. The response to question 3 is shown in [Fig. 3](#fig3){ref-type="fig"} and 84% of respondents were consultants and 12% were trainee surgeons.Fig. 1What is your surgical specialty? \[n = 68\].Fig. 1Fig. 2In what region are you based? \[n = 68\].Fig. 2Fig. 3What is your present grade? \[n = 68\].Fig. 3

The response to question 4 is shown in [Fig. 4](#fig4){ref-type="fig"} and 95% of respondents worked in either a university academic unit or a teaching hospital. The response to question 5 is shown in [Fig. 5](#fig5){ref-type="fig"} and 90% of respondents used an enhanced recovery/fast track programme following elective surgery. The response to question 6 is shown in [Fig. 6](#fig6){ref-type="fig"} and 87% of respondents carried out elective surgery via laparoscopic, robotic or another minimally invasive techniques.Fig. 4Which of the following best describes the surgical unit in which you currently practice? \[n = 68\].Fig. 4Fig. 5Does your unit currently use an "enhanced recovery" or "fast track" programme following elective surgery? \[n = 68\].Fig. 5Fig. 6Do you currently perform any elective procedures using laparoscopic, robotic or other minimally-invasive techniques? \[n = 63\].Fig. 6

The response to question 7 is shown in [Fig. 7](#fig7){ref-type="fig"} and 85% of respondents routinely used CRP in the monitoring of patients in the post-operative period and of these 91% of respondents used CRP to guide decision making in the post-operative period (Question 8, [Fig. 8](#fig8){ref-type="fig"}). The response to question 9 is shown in [Fig. 9](#fig9){ref-type="fig"} and 78% of respondents were aware of existing literature examining the relationship between the magnitude of the postoperative systemic inflammatory response including CRP and outcomes following surgery.Fig. 7Is C-reactive protein \[CRP\] measured routinely in your patients during the postoperative period following elective surgery? \[n = 67\].Fig. 7Fig. 8If you answered "yes" to Q7: Do you currently use C-reactive protein \[CRP\] to guide decision making in the postoperative period \[e.g. to trigger investigation of potential complications or direct discharge\]? \[n = 56\].Fig. 8Fig. 9Are you aware of any existing literature examining the relationship between the magnitude of the postoperative systemic inflammatory response, in particular as measured by C-reactive protein \[CRP\], and outcomes following surgery? \[n = 67\].Fig. 9

Finally, the response to question 10 is shown in [Fig. 10](#fig10){ref-type="fig"} and 81% of respondents considered that measures of the postoperative systemic inflammatory response, such as CRP, should be included in postoperative care protocols or guidelines to guide postoperative decision making and/or discharge planning.Fig. 10Do you think that a measure of the postoperative systemic inflammatory response, such as C-reactive protein \[CRP\], should be included in postoperative care protocols or guidelines to guide postoperative decision making and/or discharge planning? \[n = 63\].Fig. 10

4. Discussion {#sec4}
=============

The results of the present study showed that most respondents were colorectal specialists, European, of consultant grade and worked in Academic Units/Teaching Hospitals. The majority practiced enhanced recovery protocols and used markers of the systemic inflammatory response (i.e. CRP) in the postoperative period to monitor patients and guide discharge. Therefore, of those surgeons with an expressed interest in post-operative management of elective surgery the majority reported that they monitored CRP and considered that a measure of the post-operative systemic inflammatory response should be incorporated into clinical guidelines.

C-reactive protein is the prototypical marker of the systemic inflammatory response reflecting the magnitude of injury [@bib14]. In the context of cancer there is concern that CRP may also be raised in the post-operative period as part of an immune response to the release of tumour antigens. However, the peak operative CRP concentrations are similar following surgery for benign or malignant disease irrespective of open or laparoscopic surgery [@bib15].

Although the majority of survey respondents were at consultant grade it is remarkable, given that the initial reports of the clinical utility of post-operative CRP concentrations were reported less than a decade ago, that this group of surgeons have adopted this measure into their routine clinical practice. This is in part due to the simplicity of the approach and the explosion of interest in the post-operative systemic inflammatory response. Given the survey responses in the present study, it may be problematical, perhaps unethical, to carry out an RCT to prove the efficacy of monitoring the systemic inflammatory response using CRP in the post-operative period. Indeed, this approach is already part of an ERAS protocol following elective resections in some countries [@bib16], [@bib17].

There are a number of implications of the rapid adoption of a CRP first approach to monitoring post-operative complications in patients undergoing elective surgery. Firstly, there may be an increasing requirement for CT resources to be used earlier in the postoperative period. For example, a recent study in the Netherlands, of 399 patients undergoing major abdominal surgery, showed that CT imaging initiated by a combination of a deteriorating clinical picture and an increased CRP had a sensitivity of 91.7% and a specificity of 100% in diagnosing major complications [@bib18]. This study formed the basis of the PREcious trial that will examine continuous monitoring of the postoperative inflammatory response of days 3, 4 and 5 with the addition of a CT-scan should the threshold of CRP \> 140 mg/L be exceeded [@bib19].

Secondly, the agreed importance of the postoperative systemic inflammatory response opens up possible treatment options to reduce this response and potentially postoperative complications. For example, increased use of minimally invasive procedures such as laparoscopic/robotic surgery has led to fewer complications [@bib20]. Indeed, most centralised teaching centres are now carrying out their resectional surgery using an enhanced recovery protocol with laparoscopic/robotic techniques. There is good evidence that minimally invasive techniques also produce less surgical stress with a reduced postoperative systemic inflammatory response [@bib15]. The present survey confirms that this is the direction of travel to improve the early but safe discharge from hospital.

Also, pre-operative corticosteroids, given their proven postoperative effect in reducing nausea and vomiting and analgesic requirement, are frequently used in abdominal surgery [@bib21], [@bib22], [@bib23]. Indeed, in two recent meta-analyses the administration of preoperative corticosteroids was reported to significantly reduce postoperative complications and length of stay following abdominal surgery [@bib21], [@bib24]. Other pharmacological methods can also be used to reduce the postoperative systemic inflammatory response and thus improve outcomes. These include the use of NSAIDS, statins and H2 receptor antagonists that can reduce both the local and systemic inflammatory responses [@bib25].

The present study has a number of limitations. The overall response rate was small (6%) and less than the typical response rate of between 20 and 30% for surveys of this type. Actions known to improve survey response rate include reduced complexity of questions, reduced survey length, incentives, and the sending of reminder emails [@bib26]. In the present study the questions were intentionally made as simple as possible and their number limited to ten to encourage a response. A reminder email was sent several weeks after the initial survey was sent out to encourage respondents. However, no incentive for completing the survey was offered. In the present study there were two different cohorts. Surgeons affiliated to the ACPGBI were selected initially as a convenience cohort as their members are often surveyed on aspects of surgical care. However, the response rate was poor and a second cohort with a known interest in the field was surveyed. The response rate in this second cohort was higher although disappointingly low. Therefore, both cohorts may have selection bias. The former primarily due to the low response rate and the latter primarily due to the individuals surveyed. For example, in the first cohort interpretation of the data is difficult due to the small number of observations. Also, in the second cohort surgeons mainly employed minimal access techniques. Therefore, it may be difficult to extrapolate the results obtained to the open technique. A large majority of respondents were from large urban teaching centres and were individuals who have expressed an interest in this field. While it is true that oesophagogastric and hepatobiliary resections are now being centralised, many colonic resections are still carried out on a regional basis. Therefore, the survey results may not reflect practice in a general hospital setting. Although the present survey has a number of limitations it is useful as a first approximation of the clinical use of CRP as a post-operative tool. The present results provide a baseline against which future surveys can be compared.

In the present survey the questions were asked in the context of colorectal cancer since almost all work has been carried out in this cancer. However, recent such work and the present results may also have implications for colorectal resections in benign disease. Further investigation is warranted in benign disease.

In summary, the present study has shown that, at least in specialist surgical units, the majority of consultants measure the systemic inflammatory response, using CRP, in patients following resectional surgery. The majority use this information together with clinical findings to instigate post-operative investigations, guide management, and to guide discharge. It remains for this approach to be incorporated into postoperative care guidelines/protocols.
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